Your browser doesn't support javascript.
loading
Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force.
Ku, Eu Jeong; Kim, Kyoung Jin; Kim, Jung Hee; Kim, Mi Kyung; Ahn, Chang Ho; Lee, Kyung Ae; Lee, Seung Hun; Lee, You-Bin; Park, Kyeong Hye; Choi, Yun Mi; Hong, Namki; Hong, A Ram; Kang, Sang-Wook; Park, Byung Kwan; Seong, Moon-Woo; Kim, Myungshin; Jung, Kyeong Cheon; Jung, Chan Kwon; Cho, Young Seok; Paeng, Jin Chul; Kim, Jae Hyeon; Ryu, Ohk-Hyun; Rhee, Yumie; Kim, Chong Hwa; Lee, Eun Jig.
Afiliação
  • Ku EJ; Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea.
  • Kim KJ; Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, Korea.
  • Kim JH; Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
  • Kim MK; Division of Endocrinology and Metabolism, Department of Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Ahn CH; Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea.
  • Lee KA; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Lee SH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Korea.
  • Lee YB; Division of Endocrinology and Metabolism, Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Park KH; Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Choi YM; Division of Endocrinology and Metabolism, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea.
  • Hong N; Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea.
  • Hong AR; Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, Korea.
  • Kang SW; Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
  • Park BK; Thyroid-Endocrine Surgery Division, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
  • Seong MW; Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim M; Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Jung KC; Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Jung CK; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
  • Cho YS; Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Paeng JC; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim JH; Department of Nuclear Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Ryu OH; Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Rhee Y; Department of Internal Medicine, Hallym University Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Korea.
  • Kim CH; Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, Korea.
  • Lee EJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, Sejong General Hospital, Bucheon, Korea.
Endocrinol Metab (Seoul) ; 36(2): 322-338, 2021 04.
Article em En | MEDLINE | ID: mdl-33820394
Pheochromocytoma and paraganglioma (PPGLs) are rare catecholamine-secreting neuroendocrine tumors but can be life-threatening. Although most PPGLs are benign, approximately 10% have metastatic potential. Approximately 40% cases are reported as harboring germline mutations. Therefore, timely and accurate diagnosis of PPGLs is crucial. For more than 130 years, clinical, molecular, biochemical, radiological, and pathological investigations have been rapidly advanced in the field of PPGLs. However, performing diagnostic studies to localize lesions and detect metastatic potential can be still challenging and complicated. Furthermore, great progress on genetics has shifted the paradigm of genetic testing of PPGLs. The Korean PPGL task force team consisting of the Korean Endocrine Society, the Korean Surgical Society, the Korean Society of Nuclear Medicine, the Korean Society of Pathologists, and the Korean Society of Laboratory Medicine has developed this position statement focusing on the comprehensive and updated diagnosis for PPGLs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paraganglioma / Feocromocitoma / Neoplasias das Glândulas Suprarrenais Tipo de estudo: Diagnostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paraganglioma / Feocromocitoma / Neoplasias das Glândulas Suprarrenais Tipo de estudo: Diagnostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article